AKR7A2 Human (+)-schisandrin B multiple interactions ISO Akr7a2 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AKR7A2 mRNA] CTD PMID:31150632 AKR7A2 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 o and p'-DDT affects the expression of AKR7A2 mRNA CTD PMID:17984292 AKR7A2 Human 1,2-dimethylhydrazine multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of AKR7A5 mRNA] CTD PMID:22206623 AKR7A2 Human 1,2-dimethylhydrazine increases expression ISO Akr7a5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of AKR7A5 mRNA CTD PMID:22206623 AKR7A2 Human 1,2-naphthoquinone increases reduction EXP 6480464 AKR7A2 protein results in increased reduction of 1 and 2-naphthoquinone CTD PMID:10510318 AKR7A2 Human 14-Deoxy-11,12-didehydroandrographolide decreases expression EXP 6480464 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of AKR7A2 mRNA CTD PMID:22101062 AKR7A2 Human 16-Ketoestrone increases reduction EXP 6480464 AKR7A2 protein results in increased reduction of 16-ketoestrone CTD PMID:10510318 AKR7A2 Human 17alpha-ethynylestradiol increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of AKR7A5 mRNA CTD PMID:16926038 AKR7A2 Human 17beta-estradiol multiple interactions ISO Akr7a2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of AKR7A2 mRNA CTD PMID:26496021 AKR7A2 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 2 more ... CTD PMID:21394737 more ... AKR7A2 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of AKR7A2 mRNA CTD PMID:18796159 and PMID:33387578 AKR7A2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR7A2 mRNA CTD PMID:32109520 and PMID:34747641 AKR7A2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Akr7a5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AKR7A5 mRNA CTD PMID:21570461 AKR7A2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Akr7a5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR7A5 mRNA CTD PMID:19465110 AKR7A2 Human 2,4,6-trinitrotoluene affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Trinitrotoluene affects the expression of AKR7A2 mRNA CTD PMID:21346803 AKR7A2 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 2 more ... CTD PMID:19954255 AKR7A2 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Akr7a5 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 AKR7A2 Human 2-methylcholine affects expression EXP 6480464 beta-methylcholine affects the expression of AKR7A2 mRNA CTD PMID:21179406 AKR7A2 Human 2-nitrobenzaldehyde increases reduction EXP 6480464 AKR7A2 protein results in increased reduction of 2-nitrobenzaldehyde CTD PMID:10510318 AKR7A2 Human 2-nitrobenzaldehyde affects reduction ISO Akr7a5 (Mus musculus) 6480464 2-nitrobenzaldehyde affects the reduction of AKR7A5 protein CTD PMID:12604212 AKR7A2 Human 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of AKR7A2 protein CTD PMID:31675489 AKR7A2 Human 3,4-methylenedioxymethamphetamine decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of AKR7A2 mRNA CTD PMID:30071829 AKR7A2 Human 3-chloropropane-1,2-diol decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in decreased expression of AKR7A2 protein CTD PMID:34915118 AKR7A2 Human 3-nitrobenzaldehyde affects reduction ISO Akr7a5 (Mus musculus) 6480464 3-nitrobenzaldehyde affects the reduction of AKR7A5 protein and 3-nitrobenzaldehyde analog affects the reduction of AKR7A5 protein CTD PMID:12604212 AKR7A2 Human 3H-1,2-dithiole-3-thione increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in increased expression of AKR7A2 mRNA CTD PMID:19162173 AKR7A2 Human 4,4'-diaminodiphenylmethane decreases expression ISO Akr7a5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of AKR7A5 mRNA CTD PMID:18648102 AKR7A2 Human 4-amino-2,6-dinitrotoluene affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of AKR7A2 mRNA CTD PMID:21346803 AKR7A2 Human 4-hydroxynon-2-enal decreases response to substance EXP 6480464 AKR7A2 protein results in decreased susceptibility to 4-hydroxy-2-nonenal CTD PMID:22001351 AKR7A2 Human 4-hydroxynon-2-enal affects response to substance EXP 6480464 AKR7A2 protein affects the susceptibility to 4-hydroxy-2-nonenal CTD PMID:30849339 AKR7A2 Human 4-hydroxynon-2-enal increases response to substance EXP 6480464 AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal CTD PMID:22964423 AKR7A2 Human 4-hydroxynon-2-enal multiple interactions EXP 6480464 7-hydroxycoumarin affects the reaction [AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal] and AKR7A2 protein affects the reaction [NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal] CTD PMID:22964423 and PMID:30849339 AKR7A2 Human 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of AKR7A2 mRNA and 4-hydroxy-2-nonenal results in increased expression of AKR7A2 protein CTD PMID:22964423 and PMID:30849339 AKR7A2 Human 4-nitrobenzaldehyde affects reduction ISO Akr7a5 (Mus musculus) 6480464 4-nitrobenzaldehyde affects the reduction of AKR7A5 protein CTD PMID:12604212 AKR7A2 Human 4-nitrobenzaldehyde multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Ethacrynic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein] more ... CTD PMID:12604212 AKR7A2 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Omeprazole affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human 6-propyl-2-thiouracil affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human 7,12-dimethyltetraphene multiple interactions EXP 6480464 AKR7A2 protein results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 AKR7A2 Human 9,10-phenanthroquinone increases reduction EXP 6480464 AKR7A2 protein results in increased reduction of 9 and 10-phenanthrenequinone CTD PMID:10510318 AKR7A2 Human 9,10-phenanthroquinone multiple interactions EXP 6480464 AKR7A2 protein results in increased reduction of and affects the activity of 9 and 10-phenanthrenequinone CTD PMID:21910479 AKR7A2 Human 9,10-phenanthroquinone affects reduction ISO Akr7a5 (Mus musculus) 6480464 9 and 10-phenanthrenequinone affects the reduction of AKR7A5 protein CTD PMID:12604212 AKR7A2 Human acetamide decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 acetamide results in decreased expression of AKR7A2 mRNA CTD PMID:31881176 AKR7A2 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AKR7A2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AKR7A2 mRNA CTD PMID:32699268 AKR7A2 Human acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of AKR7A2 mRNA CTD PMID:32763439 AKR7A2 Human aflatoxin B1 increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of AKR7A2 mRNA CTD PMID:22545673 AKR7A2 Human aflatoxin B1 decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Aflatoxin B1 results in decreased expression of AKR7A2 mRNA CTD PMID:23630614 AKR7A2 Human Aflatoxin B2 alpha decreases methylation EXP 6480464 aflatoxin B2 results in decreased methylation of AKR7A2 3' UTR CTD PMID:30157460 AKR7A2 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AKR7A2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AKR7A2 mRNA CTD PMID:32699268 AKR7A2 Human amiodarone affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Amiodarone affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human ammonium chloride affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of AKR7A2 mRNA CTD PMID:16483693 AKR7A2 Human antimycin A decreases expression EXP 6480464 Antimycin A results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of AKR7A2 protein CTD PMID:33212167 AKR7A2 Human Aroclor 1254 decreases expression ISO Akr7a5 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of AKR7A5 mRNA CTD PMID:23650126 AKR7A2 Human atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of AKR7A2 mRNA and Atorvastatin results in increased expression of AKR7A2 protein CTD PMID:38484826 AKR7A2 Human azoxystrobin decreases expression EXP 6480464 azoxystrobin results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human benzbromarone affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human benzo[a]pyrene-7,8-dione multiple interactions EXP 6480464 [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7 more ... CTD PMID:21910479 AKR7A2 Human beta-naphthoflavone increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 beta-Naphthoflavone results in increased expression of AKR7A2 mRNA and beta-Naphthoflavone results in increased expression of AKR7A2 protein CTD PMID:19389873 AKR7A2 Human bisphenol A multiple interactions ISO Akr7a2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of AKR7A2 mRNA CTD PMID:26496021 AKR7A2 Human bisphenol A decreases expression ISO Akr7a5 (Mus musculus) 6480464 bisphenol A results in decreased expression of AKR7A5 mRNA CTD PMID:35598803 AKR7A2 Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of AKR7A2 gene CTD PMID:31601247 AKR7A2 Human bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of AKR7A2 gene CTD PMID:31601247 AKR7A2 Human bisphenol A increases expression ISO Akr7a5 (Mus musculus) 6480464 bisphenol A results in increased expression of AKR7A5 mRNA CTD PMID:33221593 AKR7A2 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AKR7A2 mRNA CTD PMID:30903817 AKR7A2 Human bisphenol A increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of AKR7A2 mRNA CTD PMID:30816183 AKR7A2 Human bisphenol A increases methylation ISO Akr7a2 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of AKR7A2 gene CTD PMID:28505145 AKR7A2 Human bisphenol A affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of AKR7A2 mRNA CTD PMID:25181051 AKR7A2 Human bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of AKR7A2 protein CTD PMID:34186270 AKR7A2 Human bortezomib multiple interactions EXP 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of AKR7A2 mRNA CTD PMID:25522274 AKR7A2 Human Brodifacoum increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 bromfenacoum results in increased expression of AKR7A2 protein CTD PMID:28903499 AKR7A2 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR7A2 mRNA CTD PMID:35301059 AKR7A2 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR7A2 mRNA CTD PMID:35301059 AKR7A2 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to AKR7A2 gene] CTD PMID:28238834 AKR7A2 Human chenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA CTD PMID:32152650 and PMID:33819548 AKR7A2 Human chlordecone multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to AKR7A5 gene] CTD PMID:31084621 AKR7A2 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of AKR7A2 mRNA CTD PMID:27594783 AKR7A2 Human clofibrate decreases expression ISO Akr7a5 (Mus musculus) 6480464 Clofibrate results in decreased expression of AKR7A5 mRNA CTD PMID:17585979 AKR7A2 Human clofibrate increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Clofibrate results in increased expression of AKR7A2 protein CTD PMID:16470657 AKR7A2 Human clofibrate affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Clofibrate affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of AKR7A2 mRNA CTD PMID:19376846 AKR7A2 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of AKR7A2 mRNA CTD PMID:19549813 AKR7A2 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of AKR7A2 mRNA CTD PMID:20106945 and PMID:25562108 AKR7A2 Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A2 mRNA CTD PMID:32152650 AKR7A2 Human deguelin decreases expression EXP 6480464 deguelin results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human deoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA CTD PMID:32152650 and PMID:33819548 AKR7A2 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of AKR7A2 mRNA CTD PMID:37042841 AKR7A2 Human dibutyl phthalate decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of AKR7A2 mRNA CTD PMID:21266533 AKR7A2 Human dibutyl phthalate decreases expression ISO Akr7a5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of AKR7A5 mRNA CTD PMID:17361019 and PMID:21266533 AKR7A2 Human dimethylarsinic acid multiple interactions ISO Akr7a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA CTD PMID:34876320 AKR7A2 Human dioxygen multiple interactions EXP 6480464 [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone] which results in decreased abundance of Oxygen more ... CTD PMID:21910479 AKR7A2 Human doxorubicin increases metabolic processing EXP 6480464 AKR7A2 results in increased metabolism of Doxorubicin CTD PMID:20837989 AKR7A2 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of AKR7A2 mRNA CTD PMID:30817976 AKR7A2 Human doxorubicin increases phosphorylation EXP 6480464 Doxorubicin results in increased phosphorylation of AKR7A2 protein CTD PMID:30817976 AKR7A2 Human endosulfan decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of AKR7A2 mRNA CTD PMID:29391264 AKR7A2 Human epoxiconazole increases expression ISO Akr7a5 (Mus musculus) 6480464 epoxiconazole results in increased expression of AKR7A5 mRNA CTD PMID:35436446 AKR7A2 Human etacrynic acid multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Ethacrynic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein] CTD PMID:12604212 AKR7A2 Human fenpyroximate decreases expression EXP 6480464 fenpyroximate results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human folic acid multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of AKR7A5 mRNA] CTD PMID:22206623 AKR7A2 Human FR900359 increases phosphorylation EXP 6480464 FR900359 results in increased phosphorylation of AKR7A2 protein CTD PMID:37730182 AKR7A2 Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of AKR7A2 gene CTD PMID:31601247 AKR7A2 Human furan affects binding ISO Akr7a2 (Rattus norvegicus) 6480464 furan binds to AKR7A2 protein CTD PMID:22240984 AKR7A2 Human gentamycin increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of AKR7A2 mRNA CTD PMID:33387578 AKR7A2 Human glafenine decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of AKR7A2 mRNA CTD PMID:24136188 AKR7A2 Human glutathione increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Glutathione deficiency results in increased expression of AKR7A2 mRNA CTD PMID:15345336 AKR7A2 Human glutathione multiple interactions EXP 6480464 AKR7A2 protein inhibits the reaction [Vitamin K 3 results in decreased abundance of Glutathione] CTD PMID:22001351 AKR7A2 Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA CTD PMID:32152650 and PMID:33819548 AKR7A2 Human glycocholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA CTD PMID:32152650 and PMID:33819548 AKR7A2 Human glycodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA CTD PMID:32152650 and PMID:33819548 AKR7A2 Human hexanal decreases response to substance ISO Akr7a5 (Mus musculus) 6480464 AKR7A5 protein results in decreased susceptibility to n-hexanal CTD PMID:24590062 AKR7A2 Human hydrogen peroxide multiple interactions EXP 6480464 [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone] which results in increased chemical synthesis of Hydrogen Peroxide more ... CTD PMID:21910479 AKR7A2 Human hydrogen peroxide decreases response to substance ISO Akr7a5 (Mus musculus) 6480464 AKR7A5 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:24590062 AKR7A2 Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of AKR7A2 protein CTD PMID:22964423 AKR7A2 Human hydrogen peroxide increases response to substance EXP 6480464 AKR7A2 mutant form results in increased susceptibility to Hydrogen Peroxide CTD PMID:22964423 AKR7A2 Human hypochlorous acid decreases expression ISO Akr7a5 (Mus musculus) 6480464 Hypochlorous Acid results in decreased expression of AKR7A5 mRNA CTD PMID:19376150 AKR7A2 Human indole-3-methanol increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 indole-3-carbinol results in increased expression of AKR7A5 CTD PMID:9806166 AKR7A2 Human indometacin multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Indomethacin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein] CTD PMID:12604212 AKR7A2 Human inulin multiple interactions ISO Akr7a5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AKR7A5 mRNA CTD PMID:36331819 AKR7A2 Human isatin affects reduction ISO Akr7a5 (Mus musculus) 6480464 Isatin affects the reduction of AKR7A5 protein CTD PMID:12604212 AKR7A2 Human isatin increases reduction EXP 6480464 AKR7A2 protein results in increased reduction of Isatin CTD PMID:10510318 AKR7A2 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of AKR7A2 protein CTD PMID:32959892 AKR7A2 Human L-ethionine affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Ethionine affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human leflunomide increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 leflunomide results in increased expression of AKR7A2 mRNA CTD PMID:24136188 AKR7A2 Human menadione multiple interactions EXP 6480464 AKR7A2 protein inhibits the reaction [Vitamin K 3 results in decreased abundance of Glutathione] and AKR7A2 protein inhibits the reaction [Vitamin K 3 results in increased abundance of Reactive Oxygen Species] CTD PMID:22001351 AKR7A2 Human menadione increases metabolic processing ISO Akr7a5 (Mus musculus) 6480464 AKR7A5 protein results in increased metabolism of Vitamin K 3 CTD PMID:24590062 AKR7A2 Human menadione decreases response to substance EXP 6480464 AKR7A2 protein results in decreased susceptibility to Vitamin K 3 CTD PMID:22001351 AKR7A2 Human methamphetamine decreases methylation ISO Akr7a5 (Mus musculus) 6480464 Methamphetamine results in decreased methylation of AKR7A5 promoter CTD PMID:26307267 AKR7A2 Human methylarsonic acid multiple interactions ISO Akr7a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA CTD PMID:34876320 AKR7A2 Human methylglyoxal decreases response to substance ISO Akr7a5 (Mus musculus) 6480464 AKR7A5 protein results in decreased susceptibility to Pyruvaldehyde CTD PMID:24590062 AKR7A2 Human methylglyoxal increases expression EXP 6480464 Pyruvaldehyde results in increased expression of AKR7A2 mRNA and Pyruvaldehyde results in increased expression of AKR7A2 protein CTD PMID:25451587 AKR7A2 Human methylglyoxal decreases response to substance EXP 6480464 AKR7A2 protein results in decreased susceptibility to Pyruvaldehyde CTD PMID:22001351 and PMID:25451587 AKR7A2 Human Muconic dialdehyde decreases response to substance EXP 6480464 AKR7A2 protein results in decreased susceptibility to muconaldehyde CTD PMID:22001351 AKR7A2 Human Muconic dialdehyde decreases response to substance ISO Akr7a5 (Mus musculus) 6480464 AKR7A5 protein results in decreased susceptibility to muconaldehyde analog CTD PMID:24590062 AKR7A2 Human N-nitrosomorpholine decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 N-nitrosomorpholine results in decreased expression of AKR7A2 protein CTD PMID:19716841 AKR7A2 Human NADP zwitterion multiple interactions EXP 6480464 [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone] which results in decreased abundance of Oxygen more ... CTD PMID:21910479 AKR7A2 Human NADP(+) multiple interactions EXP 6480464 [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone] which results in decreased abundance of Oxygen more ... CTD PMID:21910479 AKR7A2 Human naphthalenes multiple interactions EXP 6480464 AKR7A2 protein results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 AKR7A2 Human naringin multiple interactions ISO Akr7a5 (Mus musculus) 6480464 naringin inhibits the reaction [Acetaminophen results in decreased expression of AKR7A5 protein] CTD PMID:35166444 AKR7A2 Human nefazodone increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 nefazodone results in increased expression of AKR7A2 mRNA CTD PMID:24136188 AKR7A2 Human nimesulide increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 nimesulide results in increased expression of AKR7A2 mRNA CTD PMID:24136188 AKR7A2 Human non-2-enal decreases response to substance ISO Akr7a5 (Mus musculus) 6480464 AKR7A5 protein results in decreased susceptibility to 2-nonenal CTD PMID:24590062 AKR7A2 Human omeprazole affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Omeprazole affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human oxaliplatin multiple interactions ISO Akr7a2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKR7A2 mRNA CTD PMID:25729387 AKR7A2 Human oxaliplatin decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 oxaliplatin results in decreased expression of AKR7A2 mRNA CTD PMID:25729387 AKR7A2 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AKR7A2 mRNA more ... CTD PMID:32699268 and PMID:35430440 AKR7A2 Human ozone multiple interactions ISO Akr7a5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AKR7A5 mRNA CTD PMID:34911549 AKR7A2 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of AKR7A2 mRNA CTD PMID:25704631 AKR7A2 Human paracetamol multiple interactions ISO Akr7a5 (Mus musculus) 6480464 naringin inhibits the reaction [Acetaminophen results in decreased expression of AKR7A5 protein] CTD PMID:35166444 AKR7A2 Human paracetamol decreases expression ISO Akr7a5 (Mus musculus) 6480464 Acetaminophen results in decreased expression of AKR7A5 protein CTD PMID:35166444 AKR7A2 Human paracetamol increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of AKR7A2 mRNA CTD PMID:33387578 AKR7A2 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Akr7a5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AKR7A5 mRNA CTD PMID:36331819 AKR7A2 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of AKR7A2 protein CTD PMID:26879310 AKR7A2 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of AKR7A2 mRNA CTD PMID:19159669 AKR7A2 Human phlorizin increases expression ISO Akr7a5 (Mus musculus) 6480464 Phlorhizin results in increased expression of AKR7A2 mRNA CTD PMID:22538082 AKR7A2 Human picoxystrobin decreases expression EXP 6480464 picoxystrobin results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AKR7A2 mRNA CTD PMID:19710929 AKR7A2 Human pirinixic acid affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of AKR7A2 mRNA CTD PMID:21858171 AKR7A2 Human Propiverine affects binding ISO Akr7a2 (Rattus norvegicus) 6480464 propiverine binds to AKR7A2 protein CTD PMID:29273565 AKR7A2 Human pyrimidifen decreases expression EXP 6480464 pyrimidifen results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human quercetin multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Quercetin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein] CTD PMID:12604212 AKR7A2 Human raloxifene affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Raloxifene Hydrochloride affects the expression of AKR7A2 mRNA CTD PMID:16079270 AKR7A2 Human reactive oxygen species multiple interactions EXP 6480464 AKR7A2 protein inhibits the reaction [Vitamin K 3 results in increased abundance of Reactive Oxygen Species] CTD PMID:22001351 AKR7A2 Human rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human sodium arsenate multiple interactions ISO Akr7a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA CTD PMID:34876320 AKR7A2 Human sodium arsenite increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 sodium arsenite results in increased expression of AKR7A2 protein CTD PMID:29459688 AKR7A2 Human sodium arsenite multiple interactions ISO Akr7a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA CTD PMID:34876320 AKR7A2 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of AKR7A2 mRNA CTD PMID:38568856 AKR7A2 Human sodium fluoride decreases expression ISO Akr7a5 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of AKR7A2 protein CTD PMID:28918527 AKR7A2 Human Soman decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Soman results in decreased expression of AKR7A2 mRNA CTD PMID:19281266 AKR7A2 Human succinic semialdehyde increases reduction EXP 6480464 AKR7A2 protein results in increased reduction of succinic semialdehyde CTD PMID:10510318 AKR7A2 Human succinic semialdehyde affects reduction ISO Akr7a5 (Mus musculus) 6480464 succinic semialdehyde affects the reduction of AKR7A5 protein CTD PMID:12604212 AKR7A2 Human superoxide multiple interactions EXP 6480464 [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone] which results in increased chemical synthesis of Superoxides more ... CTD PMID:21910479 AKR7A2 Human tartrazine multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA CTD PMID:33819548 AKR7A2 Human tebufenpyrad decreases expression EXP 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 AKR7A2 Human tetrachloromethane multiple interactions ISO Akr7a2 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AKR7A2 mRNA] CTD PMID:31150632 AKR7A2 Human tetrachloromethane decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of AKR7A2 mRNA CTD PMID:31150632 AKR7A2 Human thioacetamide affects expression ISO Akr7a2 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of AKR7A2 mRNA CTD PMID:19483382 AKR7A2 Human thioacetamide decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of AKR7A2 mRNA CTD PMID:34492290 AKR7A2 Human thiram decreases expression EXP 6480464 Thiram results in decreased expression of AKR7A2 mRNA CTD PMID:38568856 AKR7A2 Human topotecan multiple interactions ISO Akr7a2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKR7A2 mRNA CTD PMID:25729387 AKR7A2 Human topotecan decreases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Topotecan results in decreased expression of AKR7A2 mRNA CTD PMID:25729387 AKR7A2 Human trichloroethene increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of AKR7A2 mRNA CTD PMID:33387578 AKR7A2 Human triphenyl phosphate increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of AKR7A2 mRNA CTD PMID:30589522 AKR7A2 Human Triptolide increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 triptolide results in increased expression of AKR7A2 protein CTD PMID:32519852 AKR7A2 Human umbelliferone increases expression EXP 6480464 7-hydroxycoumarin results in increased expression of AKR7A2 mRNA and 7-hydroxycoumarin results in increased expression of AKR7A2 protein CTD PMID:22964423 more ... AKR7A2 Human umbelliferone multiple interactions EXP 6480464 7-hydroxycoumarin affects the reaction [AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal] CTD PMID:22964423 AKR7A2 Human valproic acid multiple interactions ISO Akr7a5 (Mus musculus) 6480464 Valproic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein] CTD PMID:12604212 AKR7A2 Human vancomycin increases expression ISO Akr7a5 (Mus musculus) 6480464 Vancomycin results in increased expression of AKR7A5 mRNA CTD PMID:18930951 AKR7A2 Human vinclozolin increases expression ISO Akr7a2 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of AKR7A2 mRNA CTD PMID:22570695